Outcomes

The available evidence on HGH (somatropin) outcomes is limited in scope and strength based on the provided literature.

Cardiovascular Outcomes

Children with Short Stature: One prospective study examined cardiac and aerobic responses to growth hormone therapy in pediatric patients, measuring outcomes using VO₂max testing and speckle tracking echocardiography. However, specific numerical results are not detailed in the available evidence.

Adults with Intestinal Failure: A Phase 4 clinical trial (NCT01380366) investigated recombinant human growth hormone effects on intestinal permeability in patients with intestinal failure, though outcomes data are not provided in the available abstracts.

Drug Delivery and Administration Outcomes

Several studies focused on delivery system performance rather than clinical efficacy:

Injection Device Performance: Research evaluated different generations of digital devices for HGH therapy, measuring adherence rates and performance support metrics, though specific adherence percentages are not reported in available abstracts.
Healthcare Professional Engagement: Studies assessed how digital platform engagement by healthcare providers impacts patient adherence to recombinant HGH therapy, but quantitative adherence outcomes are not detailed.
Bioavailability: An ongoing Phase 1 trial (NCT07542886) is examining how different injector pen designs affect somatropin delivery and blood uptake in healthy adults, but results are not yet available.

Limitations of Available Evidence

The current evidence base has significant limitations:

Most studies focus on delivery methods, adherence monitoring, or device usability rather than clinical efficacy outcomes
Specific biomarker changes, symptom improvements, or quantitative clinical results are not detailed in the available abstracts
Several relevant studies appear to be ongoing or recently completed without published results

Disclaimer: This summary is based on limited available evidence. Patients should consult healthcare providers for personalized medical advice regarding HGH therapy outcomes and expectations.

HGH (Somatropin)

Member access required